Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Micro-Nanostructured Polymeric Scaffolds for Bone Tissue Engineering

June 2024 Bioprinting, Bioprocessing, Exosomes / Extracellular Vesicles, Immunomodulation, Orthopedic, Tissue Engineering

Microporous Particle Scaffolds For Mesenchymal Stromal Cell Expansion and Enhanced Immunomodulatory Function

June 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Tissue Engineering

The Effect of Different Isolation Methods on the Immunomodulatory Potency of Extracellular Vesicles Isolated from an Immortalized Mesenchymal Stromal Cell Line

June 2024 Bioprocessing, Cell Therapy, Exosomes / Extracellular Vesicles, Immunomodulation, Orthopedic

MMP-9 enhanced Mesenchymal stem cells for the treatment of liver fibrosis

June 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Gene Editing, Genetic, Immunomodulation, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Biological differences between adult and perinatal human mesenchymal stromal cells and their impact on the manufacturing processes

May 2024 Bioprinting, Cardiovascular, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Tissue Engineering

Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein

May 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Immunomodulation, Tissue Engineering

Cytokine Receptor-like Factor 1 (CRLF1) and Its Role in Osteochondral Repair

May 2024 Bioprinting, Bioprocessing, Cardiovascular, Gene Editing, Immunomodulation, Orthopedic, Tissue Engineering

Mechanical Loading and RGD-Conjugation: Influences on Mesenchymal Stem Cell Response

May 2024 Bioprinting, Immunomodulation, Orthopedic, Tissue Engineering

Regulation of vascular endothelial integrity by mesenchymal stem cell extracellular vesicles after hemorrhagic shock and trauma

May 2024 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Lung, Tissue Engineering

GMP-compliant extracellular vesicles derived from umbilical cord mesenchymal stromal cells: manufacturing and pre-clinical evaluation in ARDS treatment

May 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Lung, Tissue Engineering
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email